INSURANCE/HEALTH: Provides relative to coverage of colorectal cancer screening, colonoscopies, and associated preventive services (EN NO IMPACT See Note)
Summary
HB 1196 amends Louisiana law governing health insurance coverage for colorectal cancer screening. The bill defines “routine colorectal cancer screening” by reference to the most recently published recommendations of the American Cancer Society or the National Comprehensive Cancer Network, including the ages, family histories, and screening frequencies in those recommendations. It also clarifies that services excluded as experimental or investigational are not included in the definition.
The bill further requires that any colonoscopy performed for colorectal cancer screening be classified as a screening service, even if a polyp or other tissue is removed during the procedure. In addition, if a healthcare provider recommends a follow-up colonoscopy because of findings from a routine screening, that subsequent procedure must also be treated as routine colorectal cancer screening when it is consistent with the referenced clinical recommendations.
Impact
HB 1196 updates R.S. 22:1029(B), affecting health insurance coverage requirements for colorectal cancer screening and related preventive services in Louisiana. The practical effect is to strengthen coverage classification for screening colonoscopies and certain follow-up colonoscopies, which can influence how insurers apply deductibles, copayments, and preventive-service benefits. It primarily affects health coverage plans, insured patients, and healthcare providers performing or recommending colonoscopies.
Sentiment
The bill appears to have received broad bipartisan support and little visible opposition. It passed the House and Senate by large margins and was ultimately signed by the Governor as Act 713. The vote totals suggest general agreement with the bill’s consumer-protection and preventive-care purpose, with only a small number of dissenting votes in each chamber.
Contention
The main policy issue is how colonoscopies are categorized for insurance purposes, especially when a screening procedure becomes more involved because a polyp or tissue is removed. Supporters appear to favor ensuring that patients are not penalized with non-screening cost-sharing for procedures that begin as preventive screenings or for medically recommended follow-up colonoscopies. Any opposition likely centered on the scope of mandated insurance coverage and the potential administrative or cost implications for health plans, though the available record shows limited controversy.